Palliative Care in Hematologic Malignancies and Serious Blood Disorders (PDF)

Christina K. Ullrich, MD, MPH



Clinical Director, Pediatric Advanced Care Team (Pediatric Palliative Care)



Institute Physician, Pediatric Hematology/Oncology and Pediatric



Palliative Care, Dana-Farber Cancer Institute



Boston Children's Hospital



Associate Professor in Pediatrics, Harvard Medical School



Boston, MA



USA


Eric Roeland, MD, FAAHPM



Associate Professor, Oregon Health and Science University

Director, Symptom Science at the Knight Cancer Institute





Medical Oncology, Palliative Care


Dr. Ullrich is an Institute Physician in Pediatric Palliative Care and Pediatric Hematology/Oncology and Hematopoietic Stem Cell Transplant (HSCT) at Dana Farber Cancer Institute and Boston Children's Hospital and an Associate Professor in Pediatrics at Harvard Medical School. Having completed fellowships in both areas, as well as a health services research fellowship, she is board certified in both the subspecialties of hospice and palliative medicine and pediatric hematology/oncology.

Her main career aim is to optimize the wellbeing of children with serious illness. Through a focus on children who undergo HSCT, she aims to integrate the principles of palliative care into the care of children undergoing intense, cure-oriented treatment such as HSCT through a variety of clinical, educational and research undertakings. She has written some of the first papers on palliative care in HSCT (adult or pediatric), including one demonstrating differences in end of life outcomes associated with palliative care consultation. She is also conducting one of the largest studies of symptoms and QOL as reported by children themselves in this population. She currently serves as Vice Chair of the American Society of Transplantation and Cellular Therapies Special Interest Group for Palliative Care



Dr. Ullrich is the